Enhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells

dc.contributor.authorFranskevych, D.V.
dc.contributor.authorPrylutska, S.V.
dc.contributor.authorGrynyuk, I.I.
dc.contributor.authorGrebinyk, D.M.
dc.contributor.authorMatyshevska, O.P.
dc.date.accessioned2019-01-22T12:56:03Z
dc.date.available2019-01-22T12:56:03Z
dc.date.issued2015
dc.description.abstractAim: To evaluate the viability of leukemic cells sensitive (L1210S) and resistant (L1210R) to cisplatin, ROS production and free cytosolic Ca²⁺ concentration under treatment with cisplatin or its combination with photoexcited fullerene C₆₀. Methods: Cell viability was assessed by the MTT reduction assay. Light-emitting diode lamp (2.45 J/сm2) was used for photoexcitation of intracellular accumulated fullerene C₆₀. Free cytosolic calcium concentration ([Ca²⁺]i) and ROS production in cells were estimated with the use of fluorescent probes Indo-1 and 2′,7′-dichlorodihydrofluorescein diacetate (DCF-DA), respectively. Results: It is shown that viability of L1210R cells wasn’t changed under treatment with cisplatin in concentration range 0.1–10 μg/ml. 50% and 30% decrease of L1210S cells were observed after 24 h of incubation with cisplatin at concentrations 5 and 1 μg/ml, respectively. Intensification of extranuclear cytotoxic effects (ROS production and [Ca²⁺]iincrease) after treatment with 1 μg/ml was detected in L1210S, but not in L1210R cells. The most strongly pronounced increase of ROS production and [Ca²⁺]i in both L1210 cell lines was revealed in dynamics after combined treatment with cisplatin (1 μg/ml) and photoexcited fullerene C₆₀ (10⁻⁵ M) and was followed by decreased viability of not only L1210S, but of L1210R cells as well.. Conclusion: Combined treatment with photoexcited C₆₀ and cisplatin allowed to decrease effective concentration of cisplatin against parental L1210 cells and to increase sensibility of resistant cells to the drug. Key Words: cisplatin, L1210 cells, photoexcited fullerene C₆₀, ROS, cytosolic Ca²⁺, cell viability.uk_UA
dc.identifier.citationEnhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells / D.V. Franskevych, S.V. Prylutska, I.I. Grynyuk, D.M. Grebinyk, O.P. Matyshevska // Experimental Oncology. — 2015. — Т. 37, № 3. — С. 187-191. — Бібліогр.: 34 назв. — англ.uk_UA
dc.identifier.issn1812-9269
dc.identifier.urihttps://nasplib.isofts.kiev.ua/handle/123456789/145486
dc.language.isoenuk_UA
dc.publisherІнститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН Україниuk_UA
dc.relation.ispartofExperimental Oncology
dc.statuspublished earlieruk_UA
dc.subjectOriginal contributionsuk_UA
dc.titleEnhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cellsuk_UA
dc.typeArticleuk_UA

Файли

Оригінальний контейнер

Зараз показуємо 1 - 1 з 1
Завантаження...
Ескіз
Назва:
04-Franskevych.pdf
Розмір:
122.64 KB
Формат:
Adobe Portable Document Format

Контейнер ліцензії

Зараз показуємо 1 - 1 з 1
Завантаження...
Ескіз
Назва:
license.txt
Розмір:
817 B
Формат:
Item-specific license agreed upon to submission
Опис: